If a client has a history of pancreatitis, what action should the nurse take regarding asparaginase (Elspar) administration?

In a patient with a history of pancreatitis, it is crucial for the nurse to consult with the healthcare provider before administering asparaginase (Elspar). This is because asparaginase can potentially cause pancreatitis or exacerbate any existing conditions of the pancreas. The patient's medical history should prompt a thorough assessment of their current health status and the appropriateness of administering this medication.

By consulting with the healthcare provider, the nurse ensures that the treatment plan is safe and tailored to the individual needs of the patient. This collaborative approach helps in identifying alternative therapies or adjustments that may be necessary to mitigate risks associated with the medication in light of the patient's history. It is vital to prioritize patient safety, particularly with conditions like pancreatitis that can lead to severe complications if not managed carefully.

Monitoring for increased side effects or documenting the history without follow-up is insufficient. Simply administering the medication without any modifications disregards the potential risks associated with the drug in this context. Thus, consulting with the healthcare provider is the most appropriate and responsible action.